StockMacro
Menu

SS Innovations International

$1.27 -66% in 6 monthsMarket cap $254.9M

SSII on XNAS, Health Care, SS Innovations International Inc., job postings

Measures activity, not value. Not investment advice.

Latest quarter revenue fell 51% to $6.3M, and shares are down 79% in a year.

  • Watch12-month revenue still rose 27% to $45.9M
  • BadNet loss of $14.5M over 12 months, a net margin of -32%

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
483
Website
ssinnovations.com
Listed
Nasdaq, US
Last results
13 Aug 2026
Next results
expected around 12 Jan 2027 (an estimate: a year ago it reported on 13 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $6.3M, net loss $5.7M.
Quarter to 31 Dec 2021: revenue –, net income -$354KQuarter to 31 Mar 2022: revenue –, net income -$80KQuarter to 30 Jun 2022: revenue –, net income -$170KQuarter to 30 Sep 2022: revenue $529K, net income -$790KQuarter to 30 Sep 2022: revenue $529K, net income -$790KQuarter to 31 Dec 2022: revenue $1.4B, net income -$1.2MQuarter to 31 Dec 2022: revenue $1.4B, net income -$1.2MQuarter to 31 Mar 2023: revenue $370K, net income -$2.0MQuarter to 31 Mar 2023: revenue $370K, net income -$2.0MQuarter to 30 Jun 2023: revenue $1.9M, net income -$1.9MQuarter to 30 Jun 2023: revenue $1.9M, net income -$1.9MQuarter to 30 Sep 2023: revenue $2.2M, net income -$2.0MQuarter to 30 Sep 2023: revenue $2.2M, net income -$2.0MQuarter to 31 Dec 2023: revenue $5.9B, net income –Quarter to 31 Mar 2024: revenue $3.6M, net income -$2.8MQuarter to 31 Mar 2024: revenue $3.6M, net income -$2.8MQuarter to 30 Jun 2024: revenue $4.5M, net income -$2.9MQuarter to 30 Jun 2024: revenue $4.5M, net income -$2.9MQuarter to 30 Sep 2024: revenue $4.4M, net income -$6.1MQuarter to 30 Sep 2024: revenue $4.4M, net income -$6.1MQuarter to 31 Dec 2024: revenue $8.1M, net income -$7.5MQuarter to 31 Dec 2024: revenue $8.1M, net income -$7.5MQuarter to 31 Mar 2025: revenue $5.1M, net income -$5.7MQuarter to 31 Mar 2025: revenue $5.1M, net income -$5.7MQuarter to 30 Jun 2025: revenue $10.0M, net income -$257KQuarter to 30 Jun 2025: revenue $10.0M, net income -$257KQuarter to 30 Sep 2025: revenue $12.8M, net income -$3.7MQuarter to 30 Sep 2025: revenue $12.8M, net income -$3.7MQuarter to 31 Dec 2025: revenue $14.5M, net income -$2.5MQuarter to 31 Dec 2025: revenue $14.5M, net income -$2.5MQuarter to 31 Mar 2026: revenue $11.1M, net income -$3.6MQuarter to 31 Mar 2026: revenue $11.1M, net income -$3.6MQuarter to 30 Jun 2026: revenue $13.9M, net income -$2.7MQuarter to 30 Jun 2026: revenue $13.9M, net income -$2.7MQuarter to 30 Sep 2026: revenue $6.3M, net income -$5.7MQuarter to 30 Sep 2026: revenue $6.3M, net income -$5.7M
31 Dec 2021RevenueNet incomeNet losstallest bar $5.9B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$6.3M-$5.7M
30 Jun 2026$13.9M-$2.7M
31 Mar 2026$11.1M-$3.6M
31 Dec 2025$14.5M-$2.5M
30 Sep 2025$12.8M-$3.7M
30 Jun 2025$10.0M-$257K
31 Mar 2025$5.1M-$5.7M
31 Dec 2024$8.1M-$7.5M
30 Sep 2024$4.4M-$6.1M
30 Jun 2024$4.5M-$2.9M
31 Mar 2024$3.6M-$2.8M
31 Dec 2023$5.9B–
30 Sep 2023$2.2M-$2.0M
30 Jun 2023$1.9M-$1.9M
31 Mar 2023$370K-$2.0M
31 Dec 2022$1.4B-$1.2M
30 Sep 2022$529K-$790K
30 Jun 2022–-$170K
31 Mar 2022–-$80K
31 Dec 2021–-$354K
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $45.9M $36.1M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +27% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$14.5M -$17.1M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.07 -$0.06
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 47.7% 47.5% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -27.7% -26.3% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -31.5% -47.4% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -32.3% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $8.1M $5.7M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $18.1M $122K
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $10.0M -$5.6M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.36 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.25
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 5.5 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 5.8 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 5.1 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
SS Innovations InternationalSSII (this company) $254.9Mloss5.5+27%-31.5%
Orthofix MedicalOFIX $247.4Mloss0.30+2.1%-5.4%
OraSure TechnologiesOSUR $238.9Mloss2.1-7.5%-41.7%
NeuropaceNPCE $273.9Mloss2.9+8.9%-20.0%
Profound MedicalPROF $233.7Mloss9.9+65%-138%
Treace Medical ConceptsTMCI $282.6Mloss1.4-7.1%-27.4%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$200K

bought $300K, sold $100K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+4.0%

26 13F filers vs 25

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

0.8%

1.7M shares held by 13F filers (30 Sep 2026) of 200.6M outstanding (13 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

0%

64K shares sold short (30 Oct 2026) of 200.6M outstanding (13 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

1.1

64K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-7.6%

70K shares sold short in the report before, 64K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

26%

26% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 44%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-51%

$6.3M vs $12.8M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

28

28 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

9.3×

28 articles in the last 7 days; its usual week has 3.

Price $1.27 on 20 Nov 2026, -79% over 12 months (12-month range $1.27 to $6.73)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $5.4M in the last 12 months (the 12 months before: -$9.2M).
Revenue per quarter. Revenue $6.3M in the latest quarter, -51% on a year earlier.
Capital spending per quarter. Capital spending $54K in the latest quarter, -94% on a year earlier.
Institutional holders (13F filers). 26 13F filers reported holding it in the latest 13F quarter, +73% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 20268-K and other filingsChairman and CEO Dr. Sudhir Srivastava bought 100,000 shares for $300,000, paid by exchanging accrued unpaid compensation
13 Nov 20268-K and other filingsDr. Vishwajyoti P. Srivastava appointed President and Gary G. Lo joined as CFO, both effective Nov 6, 2026
26 Aug 20268-K and other filingsDirector or officer change
14 Jul 20268-K and other filingsDirector or officer change
26 May 20268-K and other filingsDirector or officer change
26 May 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Mar 20268-K and other filingsPrivate placement of securities (Form D)
17 Mar 2026Sharp changeQuarterly revenue change: quarterly revenue change, 14.5M vs usual 4.8M (2025-12-31); 1.8x the same period a year earlier
11 Mar 2026Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 5.2M)
2 Feb 20268-K and other filingsRegistered new securities for sale (S-1)
8 Jan 20268-K and other filingsDirector or officer change
8 Jan 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Oct 2025Sharp changeQuarterly revenue change: quarterly revenue change, 12.8M vs usual 4.4M (2025-09-30); 2.9x the same period a year earlier
26 Sep 20258-K and other filingsDirector or officer change
28 Jul 20258-K and other filingsDirector or officer change
23 May 20258-K and other filingsDirector or officer change
2 May 20258-K and other filingsDirector or officer change
2 May 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 May 2025Sharp changeQuarterly revenue change: quarterly revenue change, 14.1M vs usual 2.0M (2024-12-31); 9.9x the same period a year earlier
31 Mar 20258-K and other filingsReport will be filed late
24 Dec 2024Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 7.0M)
30 Sep 20248-K and other filingsDirector or officer change
10 Sep 20248-K and other filingsDirector or officer change
22 Aug 20248-K and other filingsDirector or officer change
22 Aug 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Aug 20248-K and other filingsEarlier financial statements can no longer be relied on
31 May 20248-K and other filingsChanged its auditor
13 May 20248-K and other filingsChanged its auditor
27 Feb 20248-K and other filingsPrivate placement of securities (Form D)
15 Feb 20248-K and other filingsDirector or officer change
14 Feb 20248-K and other filingsRegistered new securities for sale (S-1)
29 Nov 20238-K and other filingsDirector or officer change
29 Nov 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Aug 20238-K and other filingsDirector or officer change
7 Aug 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Apr 20238-K and other filingsDirector or officer change
19 Apr 20238-K and other filingsCompleted an acquisition or asset sale
19 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 May 2024: $9K published
Month from 1 Jun 2024: $7K published
Month from 1 Aug 2024: $2K published
Month from 1 Sep 2024: $2K published
Month from 1 Nov 2024: -$5.0M published
Month from 1 Dec 2024: -$5.0M published
Month from 1 Jan 2025: -$4.0M published
Month from 1 Feb 2025: -$250K published
Month from 1 Apr 2025: $44K published
Month from 1 Mar 2026: $5.2M published
Month from 1 Sep 2026: -$100K published
Month from 1 Nov 2026: $300K published
Revenue per quarter
Quarter ended 30 Sep 2022: $529K; public on 15 Jan 2025
Quarter ended 31 Dec 2022: $1.4B; public on 7 Dec 2024
Quarter ended 31 Mar 2023: $370K; public on 20 Feb 2025
Quarter ended 30 Jun 2023: $1.9M; public on 15 Jan 2025
Quarter ended 30 Sep 2023: $2.2M, +313% on a year earlier; public on 15 Jan 2025
Quarter ended 31 Dec 2023: $5.9B, +309% on a year earlier; public on 7 Dec 2024
Quarter ended 31 Mar 2024: $3.6M, +883% on a year earlier; public on 20 Feb 2025
Quarter ended 30 Jun 2024: $4.5M, +138% on a year earlier; public on 11 Mar 2025
Quarter ended 30 Sep 2024: $4.4M, +101% on a year earlier; public on 2 Apr 2025
Quarter ended 31 Dec 2024: $8.1M, -100% on a year earlier; public on 16 Apr 2025
Quarter ended 31 Mar 2025: $5.1M, +41% on a year earlier; public on 15 May 2025
Quarter ended 30 Jun 2025: $10.0M, +122% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $12.8M, +192% on a year earlier; public on 29 Oct 2025
Quarter ended 31 Dec 2025: $14.5M, +79% on a year earlier; public on 11 Mar 2026
Quarter ended 31 Mar 2026: $11.1M, +117% on a year earlier; public on 14 May 2026
Quarter ended 30 Jun 2026: $13.9M, +39% on a year earlier; public on 14 Aug 2026
Quarter ended 30 Sep 2026: $6.3M, -51% on a year earlier; public on 17 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2023: $72K; public on 20 Feb 2025
Quarter ended 30 Jun 2023: $664K; public on 8 Aug 2023
Quarter ended 30 Sep 2023: $141K; public on 14 Nov 2023
Quarter ended 30 Jun 2024: $171K, -74% on a year earlier; public on 7 Sep 2024
Quarter ended 31 Mar 2025: $873K; public on 15 May 2025
Quarter ended 31 Dec 2025: $1.7M; public on 11 Mar 2026
Quarter ended 31 Mar 2026: $54K, -94% on a year earlier; public on 14 May 2026
Institutional holders (13F filers)
30 Jun 2025 report: 12; public on 14 Aug 2025
30 Sep 2025 report: 15; public on 14 Nov 2025
31 Dec 2025 report: 24; public on 17 Feb 2026
31 Mar 2026 report: 26; public on 15 May 2026
30 Jun 2026 report: 25; public on 14 Aug 2026
30 Sep 2026 report: 26; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is total debt at period end: short- and long-term borrowings at $18.1M (30 Sep 2026), 117× its normal quarter; higher than 100% of its own history.
  • Insider net buying (open market): Insiders bought a net $5.4M in the last 12 months (the 12 months before: -$9.2M).
  • Revenue per quarter: Revenue $6.3M in the latest quarter, -51% on a year earlier.
  • Capital spending per quarter: Capital spending $54K in the latest quarter, -94% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 37 insider trades

Last 90 days: 1 sale, $100K; 1 purchase, $300K. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
17 Nov 2026Srivastava SudhirChairman and CEOBuy100,000$3.00$300KForm 4
9 Sep 2026Srivastava SudhirChairman and CEOSell33,333$3.00$100KForm 4
10 Mar 2026Frederic H MollDirector, 10% ownerBuy501,253$3.99$2.0MForm 4
10 Mar 2026Timothy P. AdamsDirectorBuy300,000$3.99$1.2MForm 4
10 Mar 2026Srivastava SudhirChairman and CEOBuy498,753$4.01$2.0MForm 4
22 Apr 2025Barry F CohenCOO - AmericasBuy426$8.92$4KForm 4
16 Apr 2025Barry F CohenCOO - AmericasBuy210$9.22$2KForm 4
10 Apr 2025Barry F CohenCOO - AmericasBuy1,000$8.91$9KForm 4

26 institutions reported shares at the end of Q3 2026, 1% of the shares outstanding; 7 opened a position, 6 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Hood River Capital Management LLC481K0.24%$1.4M-352K-42%
Inspire Investing, LLC223K0.11%$665K+37K+20%
71 West Capital Partners200K0.10%$596KNew+200K
Sagespring Wealth Partners, LLC150K0.07%$447KNew+150K
Handelsbanken Fonder AB120K0.06%No change
Eversept Partners, LP110K0.05%$327K-463-0.4%
JNBA Financial Advisors102K0.05%$305KNo change
AlphaCentric Advisors LLC50K0.02%$149KNo change
Geode Capital Management, LLC48K0.02%$143K+6,164+15%
Forum Financial Management, LP38K0.02%$115KNo change

Company events

All 46 company events

In 12 months: 6 director or officer changes, 2 major agreements, 1 share registration, 1 private placement. Results releases and routine reports are left out.

FiledWhat happenedSource
17 Nov 2026Chairman and CEO Dr. Sudhir Srivastava bought 100,000 shares for $300,000, paid by exchanging accrued unpaid compensationSame filing: sold shares privately8-K
13 Nov 2026Dr. Vishwajyoti P. Srivastava appointed President and Gary G. Lo joined as CFO, both effective Nov 6, 20268-K
13 Oct 2026Signed a major agreementSame filing: took on new debt8-K
26 Aug 2026Director or officer change8-K
14 Jul 2026Director or officer change8-K
18 Jun 2026Signed a major agreement8-K
26 May 2026Director or officer change8-K
19 Mar 2026Private placement of securities (Form D)$18.6M sold of $18.6M offeredD

The 5 newest of 128 articles that name the company.

Timeline
Kind of data

Several things at once

Two or more unrelated kinds of records unusual within 30 days

17 Mar 2026confirmed

Confirmed across sources Insiders and Filings + Financials

SS Innovations International (SSII): had 3 insiders buy $5.2M of its shares on the open market within 30 days (3 filings), while it reported revenue of $14.5M for the quarter ended 31 Dec 2025, 1.8× the same quarter last year. Two unrelated kinds of activity within 6 days.

  • Insiders: Clustered insider buying, became public on 11 Mar 2026
  • Financials: Quarterly revenue change, became public on 17 Mar 2026
2023-09-30: $2.2M2024-03-31: $3.6M2024-06-30: $4.5M2024-09-30: $4.4M2024-12-31: $8.1M2025-03-31: $5.1M2025-06-30: $10.0M2025-09-30: $12.8M2025-12-31: $14.5M
The quarter ended 31 Dec 2025 against the 8 quarters before it. this quarterearliernormal: $4.8M
See the evidence (2 changes)

Insiders: Clustered insider buying became public on 11 Mar 2026

SS Innovations International had 3 insiders buy $5.2M of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$5.2M
Window
9 Feb 2026 to 11 Mar 2026

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Financials: Quarterly revenue change became public on 17 Mar 2026

SS Innovations International reported revenue of $14.5M for the quarter ended 31 Dec 2025, 1.8× the same quarter last year.

This period
$14.5M (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
$4.8M
Typical spread (median absolute deviation)
$1.9M
How far from its usual level
+3.4
Same quarter last year
$8.1M
History used
1,188 days
2023-09-30: $2.2M2024-03-31: $3.6M2024-06-30: $4.5M2024-09-30: $4.4M2024-12-31: $8.1M2025-03-31: $5.1M2025-06-30: $10.0M2025-09-30: $12.8M2025-12-31: $14.5M
the quarter ended 31 Dec 20258 earlier quartersnormal: $4.8M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 17 Nov 2026Insiders record

    Sudhir Srivastava (Chairman and CEO) bought 100,000 shares of SSII ($300,000)

  2. 17 Nov 2026Filings record

    Chairman and CEO Dr. Sudhir Srivastava bought 100,000 shares for $300,000, paid by exchanging accrued unpaid compensation

  3. 13 Nov 2026Filings record

    Dr. Vishwajyoti P. Srivastava appointed President and Gary G. Lo joined as CFO, both effective Nov 6, 2026

  4. 26 Aug 2026Filings record

    Director or officer change

  5. 14 Jul 2026Filings record

    Director or officer change

  6. 26 May 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 26 May 2026Filings record

    Director or officer change

  8. 19 Mar 2026Filings record

    Private placement of securities (Form D)

  9. 17 Mar 2026several at once

    had 3 insiders buy $5.2M of its shares on the open market within 30 days (3 filings), while it reported revenue of $14.5M for the quarter ended 31 Dec 2025, 1.8× the same quarter last year. Two unrelated kinds of activity within 6 days.

    See the evidence (2 changes)

    Insiders: Clustered insider buying became public on 11 Mar 2026

    SS Innovations International had 3 insiders buy $5.2M of its shares on the open market within 30 days (3 filings).

    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $5.2M
    Window
    9 Feb 2026 to 11 Mar 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Financials: Quarterly revenue change became public on 17 Mar 2026

    SS Innovations International reported revenue of $14.5M for the quarter ended 31 Dec 2025, 1.8× the same quarter last year.

    This period
    $14.5M (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    $4.8M
    Typical spread (median absolute deviation)
    $1.9M
    How far from its usual level
    +3.4
    Same quarter last year
    $8.1M
    History used
    1,188 days
    2023-09-30: $2.2M2024-03-31: $3.6M2024-06-30: $4.5M2024-09-30: $4.4M2024-12-31: $8.1M2025-03-31: $5.1M2025-06-30: $10.0M2025-09-30: $12.8M2025-12-31: $14.5M
    the quarter ended 31 Dec 20258 earlier quartersnormal: $4.8M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  10. 17 Mar 2026Financials change

    reported revenue of $14.5M for the quarter ended 31 Dec 2025, 1.8× the same quarter last year.

    Same quarter last year: $8.1M; its normal quarter is $4.8M.

    See the evidence
    This period
    $14.5M (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    $4.8M
    Typical spread (median absolute deviation)
    $1.9M
    How far from its usual level
    +3.4
    Same quarter last year
    $8.1M
    History used
    1,188 days
    2023-09-30: $2.2M2024-03-31: $3.6M2024-06-30: $4.5M2024-09-30: $4.4M2024-12-31: $8.1M2025-03-31: $5.1M2025-06-30: $10.0M2025-09-30: $12.8M2025-12-31: $14.5M
    the quarter ended 31 Dec 20258 earlier quartersnormal: $4.8M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  11. 11 Mar 2026Insiders change

    had 3 insiders buy $5.2M of its shares on the open market within 30 days (3 filings).

    Who bought: Sudhir Srivastava, Adams Timothy P., Moll Frederic H.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $5.2M
    Window
    9 Feb 2026 to 11 Mar 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  12. 11 Mar 2026Insiders record

    MOLL FREDERIC H (director) bought 501,253 shares of SSII ($2.0M) (dated 10 Mar 2026)

  13. 11 Mar 2026Insiders record

    Adams Timothy P. (director) bought 300,000 shares of SSII ($1.2M) (dated 10 Mar 2026)

  14. 11 Mar 2026Insiders record

    Sudhir Srivastava (Chairman and CEO) bought 498,753 shares of SSII ($2.0M) (dated 10 Mar 2026)

  15. 2 Feb 2026Filings record

    Registered new securities for sale (S-1)

  16. 8 Jan 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  17. 8 Jan 2026Filings record

    Director or officer change

  18. 30 Oct 2025Financials change

    reported revenue of $12.8M for the quarter ended 30 Sep 2025, 2.9× the same quarter last year.

    Same quarter last year: $4.4M; its normal quarter is $4.4M.

    See the evidence
    This period
    $12.8M (the quarter ended 30 Sep 2025)
    Normal quarter (median of 8 earlier)
    $4.4M
    Typical spread (median absolute deviation)
    $1.5M
    How far from its usual level
    +3.7
    Same quarter last year
    $4.4M
    History used
    1,096 days
    2023-09-30: $2.2M2023-12-31: $1.4M2024-03-31: $3.6M2024-06-30: $4.5M2024-09-30: $4.4M2024-12-31: $14.1M2025-03-31: $5.1M2025-06-30: $10.0M2025-09-30: $12.8M
    the quarter ended 30 Sep 20258 earlier quartersnormal: $4.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  19. 26 Sep 2025Filings record

    Director or officer change

  20. 28 Jul 2025Filings record

    Director or officer change

  21. 1 Jul 2025Insiders record

    Cohen Barry F (COO - Americas) bought 426 shares of SSII ($3,799) [amended] (dated 30 Jun 2025)

  22. 23 May 2025Filings record

    Director or officer change

  23. 2 May 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  24. 2 May 2025Filings record

    Director or officer change

  25. 1 May 2025Financials change

    reported revenue of $14.1M for the quarter ended 31 Dec 2024, 9.9× the same quarter last year.

    Same quarter last year: $1.4M; its normal quarter is $2.0M.

    See the evidence
    This period
    $14.1M (the quarter ended 31 Dec 2024)
    Normal quarter (median of 8 earlier)
    $2.0M
    Typical spread (median absolute deviation)
    $1.4M
    How far from its usual level
    +5.9
    Same quarter last year
    $1.4M
    History used
    823 days
    2022-12-31: $907K2023-03-31: $370K2023-06-30: $1.9M2023-09-30: $2.2M2023-12-31: $1.4M2024-03-31: $3.6M2024-06-30: $4.5M2024-09-30: $4.4M2024-12-31: $14.1M
    the quarter ended 31 Dec 20248 earlier quartersnormal: $2.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  26. 23 Apr 2025Insiders record

    Cohen Barry F (COO - Americas) bought 426 shares of SSII ($3,799) (dated 22 Apr 2025)

  27. 17 Apr 2025Insiders record

    Cohen Barry F (COO - Americas) bought 210 shares of SSII ($1,936) (dated 16 Apr 2025)

  28. 11 Apr 2025Insiders record

    Cohen Barry F (COO - Americas) bought 1,000 shares of SSII ($8,906) (dated 10 Apr 2025)

  29. 3 Apr 2025Insiders record

    Cohen Barry F (COO - Americas) bought 3,090 shares of SSII ($29,847) (dated 2 Apr 2025)

  30. 31 Mar 2025Filings record

    Report will be filed late

  31. 25 Feb 2025Insiders record

    MOLL FREDERIC H (director) bought 3,645,224 shares of SSII ($5.0M) (dated 24 Feb 2025)

  32. 19 Feb 2025Insiders record

    Adams Timothy P. (director) bought 1,250,000 shares of SSII ($1.7M) (dated 18 Feb 2025)

  33. 14 Feb 2025Insiders record

    Cohen Barry F (COO - Americas) bought 530 shares of SSII ($4,725) [amended] (dated 13 Feb 2025)

  34. 24 Jan 2025Insiders record

    Cohen Barry F (COO - Americas) bought 530 shares of SSII ($4,725) (dated 23 Jan 2025)

  35. 11 Jan 2025Insiders record

    MOLL FREDERIC H (director) bought 1,457,726 shares of SSII ($2.0M) (dated 10 Jan 2025)

  36. 4 Jan 2025Insiders record

    MOLL FREDERIC H (director) bought 2,186,589 shares of SSII ($3.0M) (dated 3 Jan 2025)

  37. 31 Dec 2024Insiders record

    Cohen Barry F (COO - Americas) bought 629 shares of SSII ($5,102) (dated 30 Dec 2024)

  38. 24 Dec 2024Insiders change

    had 3 insiders buy $7.0M of its shares on the open market within 30 days (3 filings).

    Who bought: Moll Frederic H, Adams Timothy P., Cohen Barry F.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $7.0M
    Window
    24 Nov 2024 to 24 Dec 2024

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  39. 24 Dec 2024Insiders record

    Cohen Barry F (COO - Americas) bought 719 shares of SSII ($3,796) (dated 23 Dec 2024)

  40. 12 Dec 2024Insiders record

    Adams Timothy P. (director) bought 1,400,620 shares of SSII ($2.0M) (dated 11 Dec 2024)

Showing the newest 40 of 81 entries; narrow the window or the kind of data to see older ones.

Not listed: 128 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001676163
Ticker
SSII
Domain
ssinnovations.com
Hq location
|GURUGRAM|12201 (1 unverified)
Name
AVRA Medical Robotics, Inc., SS Innovations International Inc.
  • SEC Form 13F institutional holdings54 data points30 Jun 2025 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)158 records3 Jun 2016 to 19 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)510 data points31 Dec 2015 to 13 Nov 2026
  • SEC Form 4 insider transactions37 records, 108 data points21 May 2024 to 17 Nov 2026
  • FINRA short interest (twice monthly)119 data points29 Sep 2023 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)794 data points25 Apr 2025 to 20 Nov 2026